StemCell Therapy

GlobeNewswire

BEIJING, China, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Li Auto Inc. (Li Auto or the Company) (Nasdaq: LI), an innovator in Chinas new energy vehicle market, today announced that in October 2020 the Company delivered 3,692 Li ONEs, representing a steady increase compared to September. In October, the Company also achieved strong orders, setting a new monthly record. 2020 Q12020 Q22020 Q32020 JanOct Deliveries2,8966,6048,66021,852 As of October 31, 2020, the Company had 41 retail stores covering 36 cities. Going forward, the Company plans to continue strengthening its direct sales and servicing network to further bolster its footprint and market penetration in China.About Li Auto Inc.Li Auto Inc. is an innovator in Chinas new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric SUVs. Through innovative products, technology, and business model, the Company provides customers with safe, convenient, and cost-effective mobility solutions. Li Auto is the first to successfully commercialize extended-range electric vehicles in China. The Company started volume production of its first model, Li ONE, in November 2019. With Li ONE, the Company leverages its in-house technology to create value for its customers, focusing on range extension, smart technology, and autonomous driving solutions. Beyond Li ONE, the Company aims to expand its product line by developing new vehicles to target a broader consumer base.For more information, please visit: http://ir.lixiang.com.Safe Harbor StatementThis press release contains statements that may constitute forward-looking statements pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will, expects, anticipates, aims, future, intends, plans, believes, estimates, likely to, and similar statements. Li Auto may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the SEC), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Li Autos beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Li Autos strategies, future business development, and financial condition and results of operations; Li Autos limited operating history; risks associated with extended-range electric vehicles, Li Autos ability to develop, manufacture, and deliver vehicles of high quality and appeal to customers; Li Autos ability to generate positive cash flow and profits; product defects or any other failure of vehicles to perform as expected; Li Autos ability to compete successfully; Li Autos ability to build its brand and withstand negative publicity; cancellation of orders for Li Autos vehicles; Li Autos ability to develop new vehicles; and changes in consumer demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Li Autos filings with the SEC. All information provided in this press release is as of the date of this press release, and Li Auto does not undertake any obligation to update any forward-looking statement, except as required under applicable law.For investor and media inquiries, please contact:Li Auto Inc. Investor Relations Email: ir@lixiang.comThe Piacente Group, Inc. Yang Song Tel: +86-10-6508-0677 Email: Li@tpg-ir.comBrandi Piacente Tel: +1-212-481-2050 Email: Li@tpg-ir.com

Visit link:
Will Trevor Lawrence stay at Clemson to avoid the Jets? - Yahoo! Voices

This entry was posted on November 2, 2020 at 3:51 am and is filed under Legal Issues Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |